By Biovian Ltd
To get in touch with Biovian heads for Bio Europe Spring in Turin, simply fill out the form below.
Subscribe to Supplier
Biovian heads for Bio Europe Spring in Turin
Turku, Finland: – Biopharmaceutical CMO Biovian is making its CEO, Dr. Knut Ringbom, available for one-to-one meetings at the big Bio-Europe conference in Turin later this month. He plans to reveal latest developments in Biovian’s distinctive “gene to finished vial” end-to-end GMP service.
Dr. Ringbom will be available via the conference’s web-based partneringONE system to set up in-depth discussions on biopharma research or manufacturing projects that require the Finnish contract manufacturer’s extensive range of cGMP manufacturing and development services.
One stop shop
“This is our tenth appearance at a Bio-Europe event,” said Dr. Ringbom. “In Turin and over the online partnering system, I will be available to provide in-depth information on our biopharmaceutical manufacturing capabilities and our latest developments.”
“Once again, I’m looking forward to arranging productive meetings with existing and prospective partners, showing them how Biovian has become a true ‘one stop shop’ CMO for GMP manufacture of biopharmaceuticals,” he added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 2,300 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labelling, packaging, storage and QP release services.
Biovian also provides development services that cover cell line, process and analysis.
About Bio-Europe Spring
The BIO-Europe Spring® Conference is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, aiming to provide life science companies with further high caliber partnering opportunities.
The 2014 Bio-Europe Spring event is being held on March 10-12 at the Oval Lingotto exhibition center in Turin, Italy.
BIO-Europe Spring has been running since 2006 and annually attracts top international executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.
More than 2,000 people attended the 2013 Bio Spring event in Barcelona, representing some 1,200 companies and organizations from 50 countries, along with 56 exhibitors. The 2013 event featured more than 130 presentations and 19 workshops. The sophisticated EBD web-based partneringONE system was used to facilitate more than 10,800 one-to-one meetings, with some 2,100 licensing opportunities posted.
Dr. Knut Ringbom, CEO, Biovian Ltd
Tel: +358 2 27488 77